K
kill-9
Guest
Tetrahydrocannabinol, the active ingredient in marijuana, has attracted a lot of attention from drugs companies, and not just because of its psychoactive effects at staff parties.
The compound has a number of potential therapeutic benefits, such as being an appetite stimulator for people with AIDS or cancer patients undergoing chemotherapy.
But fabricating the compound isn't easy. Tetrahydrocannabinol is destroyed by heat and light, and is easily oxidised in air.
For these reasons, the various ways of making it are either unfeasibly long, or result in a disappointingly low yield. Which is why the Johnson Matthey company (JM) in London, UK, is excited about its latest breakthrough in which it reacts together a diester and olivetol to synthesize tetrahydrocannabinol.
JM says the yield can reach 75%, and the process can easily be scaled up to industrial levels.
Read the full patent: http://tinyurl.com/2uckse
The compound has a number of potential therapeutic benefits, such as being an appetite stimulator for people with AIDS or cancer patients undergoing chemotherapy.
But fabricating the compound isn't easy. Tetrahydrocannabinol is destroyed by heat and light, and is easily oxidised in air.
For these reasons, the various ways of making it are either unfeasibly long, or result in a disappointingly low yield. Which is why the Johnson Matthey company (JM) in London, UK, is excited about its latest breakthrough in which it reacts together a diester and olivetol to synthesize tetrahydrocannabinol.
JM says the yield can reach 75%, and the process can easily be scaled up to industrial levels.
Read the full patent: http://tinyurl.com/2uckse
